Ignite Creation Date:
2024-05-06 @ 4:53 PM
Last Modification Date:
2024-10-26 @ 2:18 PM
Study NCT ID:
NCT05122182
Status:
TERMINATED
Last Update Posted:
2023-09-15
First Post:
2021-11-14
Brief Title:
Controlled Trial of Angiotensin Receptor Blocker ARB Chemokine Receptor Type 2 CCR2 Antagonist for the Treatment of COVID-19
Sponsor:
University of Sydney
Organization:
University of Sydney
Organization Data
Organization:
University of Sydney
Class:
OTHER
Study ID:
CTC0312
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Sydney
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| The George Institute for Global Health India | UNKNOWN |